Business Wire

TOURISE Awards 2025: Tokyo, New York, Ancash and Paris Take Top Honors at Inaugural TOURISE Awards

12.11.2025 20:31:00 EET | Business Wire | Press release

Share

The very first winners of the TOURISE Awards have been announced, recognizing the destinations redefining exploration, hospitality, and cultural connection for the modern traveler, setting new benchmarks for innovation and excellence to deliver truly unforgettable visitor experiences.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251112648089/en/

His Excellency Ahmed Al-Khateeb, Minister of Tourism and TOURISE Chairman, celebrates with the winners of the TOURISE Awards

Taking place as part of the inaugural TOURISE Summit, held under the patronage of His Royal Highness Prince Mohammed bin Salman bin Abdulaziz Al Saud, Crown Prince and Prime Minister, Tokyo, Japan, emerged as the big winner, clinching the coveted title of Best Overall Destination. In addition, Tokyo was also recognized as both the Best Food & Culinary and Best Entertainment destination, affirming its status as a global capital of innovation, energy, and unforgettable experiences.

2025 Individual Category Winners

Selected by an independent cross-sector jury and chosen from an extensive slate of nominations submitted by travelers, industry leaders, and organizations worldwide, this year’s winners exemplify soul stirring culture, boundary pushing experiences, and meaningful, lasting memories. The winners represent destinations that have elevated culture and the arts into immersive experiences, took adventure to new levels, transformed local produce into world‑class culinary ecosystems, redefined retail as creative placemaking, and animated cityscapes with boundary‑breaking entertainment.

The category winners for this year are:

  • Best Arts & Culture Destination: New York, USA - An urban metropolis where marquee museums and world stages meet off-Broadway neighborhood soul and you can find your scene on any corner.
  • Best Adventure Destination: Ancash, Peru - The iconic site of adventures which anchors classic Andean bucket-list adventure amid the Cordillera Blanca’s turquoise lakes, high-altitude trails, and dramatic summits.
  • Best Food & Culinary Destination: Tokyo, Japan - A world-renowned capital that marries unrivaled culinary depth, from humble counters to multi-course kaiseki innovation.
  • Best Shopping Destination: Paris, France - The elite “City of Lights” and global capital of couture, fusing living heritage with a contemporary edge while reimagining shopping as cultural discovery through ateliers, concept stores, and revitalized districts.
  • Best Entertainment Destination: Tokyo, Japan - From globally recognized theme parks and immersive indoor attractions to a forward-looking music and cultural scene, Tokyo truly has something for everyone.

“Tonight’s winners are not just places on a map, they are living, breathing inspirations that unite cultures and spark imaginations,” His Excellency Ahmed Al-Khateeb, Minister of Tourism and Chairman of the Board of TOURISE, said. His Excellency continued, “TOURISE is shaping the next 50 years of travel, and these destinations define what purposeful and transformative tourism can achieve. Each reflects what today’s traveler increasingly seeks; authenticity, creativity, and experiences that connect people to place and purpose. We take inspiration from their vision and ambition, as together we shape a tourism future that inspires progress, strengthens communities, and brings the world closer together.”

A Night to Remember

The prestigious awards were presented at a dazzling gala dinner at Riyadh’s Ritz-Carlton, with a culinary journey curated by chef Nawal Alkhalawi and a show-stopping live performance by international vocal sensation Loren Allred who captivated the room in a stunning gown by Saudi fashion designer Mashael Al Faris, paired with exquisite jewelry from APOA (A Piece of Art) - a Saudi brand born in Riyadh. The night embodied the spirit of global hospitality and cultural exchange that sits at the heart of the TOURISE vision. With a focus on storytelling through the language of food, the menu paid tribute to Saudi Arabia’s diverse regional cuisines, thoughtfully infused with global influences to surprise and delight guests.

Judged by Global Icons

The Awards’ independent, cross-sector jury panel included former leaders of Forbes Travel Guide, Michelin Guides, Tate Modern, Condé Nast, the British Fashion Council, and more, bringing together unrivaled expertise from across the worlds of travel, fashion, food, and entertainment.

The panel included:

  • Filip Boyen, Former CEO, Forbes Travel Guide
  • Michael Ellis, Former Global Director, Michelin Guides
  • Fiona Jeffery, Former Chair, World Travel Market; Former Chair, Tourism for Tomorrow Awards
  • Renaud de Lesquen, Former CEO, Givenchy; Former President, Dior AM
  • Lars Nittve, Former Founding Director, Tate Modern
  • Albert Read, Former Managing Director, Condé Nast
  • Caroline Rush, Former CEO, British Fashion Council
  • Omar Samra, UN Goodwill Ambassador, Mountaineer and Polar Explorer
  • Bernold Schroeder, Former CEO, Kempinski; Pan Pacific

With the 2025 TOURISE Awards winners now announced, a new benchmark has been set across culture, cuisine, adventure, and entertainment. As the journey continues, TOURISE is committed to uncovering and celebrating destinations that surprise and delight a new generation of travelers, destinations that spark curiosity, forge connections, and create unforgettable memories. Together with our global community, we look forward to the next chapter and the next remarkable destinations to shine.

About the TOURISE Awards

The TOURISE Awards are a global celebration of destination excellence, recognizing places that deliver travel experiences that are purposeful, unforgettable, and aligned with the evolving expectations of today’s travelers.

Judged by a prestigious cross-sector jury, the Awards honor destinations across five categories - Arts & Culture, Adventure, Food & Culinary, Shopping, and Entertainment - culminating in the flagship Best Overall Destination award. The Awards spotlight innovation, sustainability, cultural preservation, and visitor impact, setting a new global standard for what makes a destination truly exceptional.

Find out more about the TOURISE Awards at https://www.tourise.com/en/awards

About TOURISE

TOURISE is the world’s premier platform shaping a new horizon for global tourism.

Under the umbrella of the Saudi Ministry of Tourism, powered by the Saudi Tourism Authority, the inaugural TOURISE Summit will take place November 11–13, 2025, in Riyadh, Saudi Arabia.

The event will convene visionaries from government, business, investment, tourism, and technology to drive transformative deals and deliver high-impact initiatives that redefine the future of the global tourism industry.

TOURISE ensures worldwide participation while offering access to decision-makers shaping the industry’s evolution. Following the Summit, TOURISE will continue as a year-round platform where bold ideas turn into real-world solutions.

This is where the next 50 years of tourism are shaped. Together, we are unstoppable.

For more information visit www.tourise.com

View source version on businesswire.com: https://www.businesswire.com/news/home/20251112648089/en/

Contacts

For media enquiries please contact: media@TOURISE.com - media@tourise.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

www.businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Galderma Receives U.S. FDA Approval for Differin ® Epiduo ® Acne Gel Prescription-to-OTC Switch22.5.2026 19:25:00 EEST | Press release

Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) use in ages 12 years and older, marking a significant Prescription-to-OTC transition in acne care. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260522074280/en/ The U.S. FDA approves Differin® Epiduo® Acne Gel Prescription-to-OTC switch This milestone represents yet another example of Galderma’s unique Integrated Dermatology strategy, demonstrating how proven innovations from its Therapeutic Dermatology portfolio can further strengthen its Dermatological Skincare offerings. The Prescription‑to‑OTC transition highlights Galderma’s scale and expertise in successfully commercializing dermatology innovations across the full spectrum of acne care. With the appro

Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 17:18:00 EEST | Press release

Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260522186975/en/ Adam Plich, CEO and Co-Founder of Avanzanite Bioscience. “Thalassaemia is a complex, chronic and multisystem disease characterised by anaemia, ineffective erythropoiesis and haemo

ICE Brent and ICE WTI Perpetual Futures to Launch on OKX22.5.2026 15:30:00 EEST | Press release

OKX, a blockchain technology and trading company serving more than 120 million customers globally,and Intercontinental Exchange (NYSE: ICE), one of the world's leading providers of financial market technology and data powering global capital markets including the New York Stock Exchange, today announced plans for OKX to launch perpetual futures based on ICE's Brent Crude and WTI Crude energy benchmarks. The products are expected to be available to trade on OKX’s platform in jurisdictions where OKX is licensed to offer perpetual futures products. The new OKX contracts represent a major step forward in expanding regulated access to global commodity markets through digital asset infrastructure. This first product collaboration between OKX and ICE comes after the companies established a strategic relationship in March 2026. ICE operates some of the world’s leading exchanges, clearing houses and market data services across energy, commodities, fixed income and equities markets. ICE’s future

Enhertu ® Recommended for Approval in the EU by CHMP for Patients with Previously Treated HER2 Positive Metastatic Solid Tumors22.5.2026 15:00:00 EEST | Press release

Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the treatment of adult patients with unresectable or metastatic HER2 positive (immunohistochemistry [IHC] 3+) solid tumors who have received prior treatment and who have no satisfactory treatment options. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from patients with HER2 positive (IHC 3+) tumors in three phase 2 trials including DESTINY-PanTumor02,DESTINY-Lung01 andDESTINY-CRC02 where Enhertu demonstrated clinically meaningful responses across a broad range of tumors. The recommendation will now be reviewed by the European Commission, which has the authority

Future Health Challenge Awards USD 300,000 to Early Detection and Population Health Sensing Tools on Sidelines of World Health Assembly22.5.2026 14:45:00 EEST | Press release

Three global teams developing early detection and real-time population health monitoring solutions have secured a total of USD 300,000 on the sidelines of the 79th World Health Assembly. The winning solutions address critical challenges in early detection, continuous population insight and more timely decision making, signalling a shift in health systems from late-stage treatment to earlier intervention. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260522587414/en/ Selected from 393 submissions across 68 countries, the winning teams were recognised through the inaugural ‘Future Health Challenge 2026: Building Anticipatory Health Systems through Population Sensing’, delivered by Future Health – A Global Initiative by Abu Dhabi in collaboration with MIT Solve. Health systems globally are facing rising costs and persistent delays in diagnosis, with many conditions still identified only after symptoms become severe. At the sam

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye